Do the Meta-Analyses Provide a Clean Bill of Health to the Use of Renin-angiotensin System Inhibitors in Coronavirus Disease 2019 (COVID-19)?

Chia Siang Kow; Syed Shahzad Hasan

doi:10.1093/cid/ciaa1167

Do the Meta-Analyses Provide a Clean Bill of Health to the Use of Renin-angiotensin System Inhibitors in Coronavirus Disease 2019 (COVID-19)?

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	164-165
Number of pages	2
Journal	Clinical Infectious Diseases
Volume	73
Issue number	1
Early online date	8 Aug 2020
DOIs	https://doi.org/10.1093/cid/ciaa1167
Publication status	Published - 1 Jul 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/cid/ciaa1167Licence: Unspecified

Cite this

@article{06d4e40075484dbcb67c2a31875c78db,

title = "Do the Meta-Analyses Provide a Clean Bill of Health to the Use of Renin-angiotensin System Inhibitors in Coronavirus Disease 2019 (COVID-19)?",

keywords = "Meta-analyses, Renin-angiotensin system inhibitors, COVID-19",

author = "Kow, {Chia Siang} and Hasan, {Syed Shahzad}",

note = "Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine",

year = "2021",

month = jul,

day = "1",

doi = "10.1093/cid/ciaa1167",

language = "English",

volume = "73",

pages = "164--165",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",